Neuronex’s NXCL-4950 wins global technology award

Published: 2010-09-15 06:56:00

Updated: 2010-09-15 06:56:00

Neuronex Co., a Korean biopharmaceutical co company, says its peripheral blood vessel vasodilator ‘NXCL-4950’ received a special technology award in the 10th Moscow International Salon of Innovations and Investments, which was held From 7th to 10th of September, 2010 in Gostini Dvor.

Moscow in...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK